| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/12/2012 | US20120087997 Edible products with thermostatic and cognitive effects |
| 04/12/2012 | US20120087989 Use of gelled prp (platelet gel) for volumetric breast reconstruction |
| 04/12/2012 | US20120087986 Pharmaceutical formulations comprising desvenlafaxine |
| 04/12/2012 | US20120087982 Extended release opioid abuse deterrent compositions and methods of making same |
| 04/12/2012 | US20120087980 Stimulation of neuroregeneration by flavonoid glycosides |
| 04/12/2012 | US20120087952 Pulmonary Delivery in Treating Disorders of the Central Nervous System |
| 04/12/2012 | US20120087940 Vector for treating alzheimer's disease |
| 04/12/2012 | US20120087934 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 04/12/2012 | US20120087925 Method for the treatment of inflammatory disorders |
| 04/12/2012 | US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/12/2012 | US20120087912 Treatment methods using dkk-1 antibodies |
| 04/12/2012 | US20120087904 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer |
| 04/12/2012 | US20120087896 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays |
| 04/12/2012 | US20120087895 Probiotic Therapies for Autism |
| 04/12/2012 | US20120087894 Producer cells for replication competent retroviral vectors |
| 04/12/2012 | US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances |
| 04/12/2012 | US20120087869 Methods for distributing agents to areas of brain |
| 04/12/2012 | US20120087861 Human Anti-Tau Antibodies |
| 04/12/2012 | US20120087858 Dual variable domain immunoglobulins and uses thereof |
| 04/12/2012 | CA2816595A1 Combination therapy for the treatment of depression and other non-infectious diseases |
| 04/12/2012 | CA2814084A1 Inhibitors of polo-like kinase |
| 04/12/2012 | CA2813704A1 Quinazoline compounds as sodium channel blockers |
| 04/12/2012 | CA2813606A1 Probiotic therapies for autism |
| 04/12/2012 | CA2813570A1 Porphyrin treatment of neurodegenerative diseases |
| 04/12/2012 | CA2812926A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 04/12/2012 | CA2812921A1 Picropodophyllin polymorphs b or c for use in cancer therapy |
| 04/12/2012 | CA2812855A1 Hdac inhibitors to treat charcot-marie-tooth disease |
| 04/11/2012 | EP2439209A1 Endokinin c/d-origin peptides |
| 04/11/2012 | EP2439205A1 Carboxamide compounds and their use as calpain inhibitors |
| 04/11/2012 | EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier |
| 04/11/2012 | EP2439203A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/11/2012 | EP2439201A1 Compounds with combined SERT, 5-HT3 and 5-HT1A activity |
| 04/11/2012 | EP2439197A1 Substituted benzimidazole derivatives as melanocortin 4 receptor antagonists |
| 04/11/2012 | EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 04/11/2012 | EP2438921A1 23-O-Acetylshengmanol-3-O-beta-D-xylopyranoside and its medical use |
| 04/11/2012 | EP2438917A1 Transdermal preparation |
| 04/11/2012 | EP2438916A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound |
| 04/11/2012 | EP2438913A1 A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling |
| 04/11/2012 | EP2438070A1 Glycine b antagonists |
| 04/11/2012 | EP2438069A1 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators |
| 04/11/2012 | EP2438067A1 New compounds |
| 04/11/2012 | EP2438060A1 Active metabolite of a thrombin receptor antagonist |
| 04/11/2012 | EP2438050A1 Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products |
| 04/11/2012 | EP2438043A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 04/11/2012 | EP2438041A1 Pyrazine carboxamide orexin receptor antagonists |
| 04/11/2012 | EP2438037A1 Glycine b antagonists |
| 04/11/2012 | EP2437745A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 04/11/2012 | EP2437744A2 Modulation of kcnq potassium channel activity for treatment of psychiatric disorders and the symptoms thereof |
| 04/11/2012 | EP2437742A1 New compositions for treating cmt and related disorders |
| 04/11/2012 | EP2437603A1 Methods of treating hepatic encephalopathy |
| 04/11/2012 | EP2310383B8 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 04/11/2012 | EP2119718B1 Macrocyclic compound |
| 04/11/2012 | EP2109465B1 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
| 04/11/2012 | EP2054390B1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 04/11/2012 | EP1957082B1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 04/11/2012 | EP1948689B1 High activity growth factor mutants |
| 04/11/2012 | EP1948667B1 Thiazolo[4,5-c]pyridine derivatives as mglu5 receptor antagonists |
| 04/11/2012 | EP1858912B1 Compounds for reducing aggregation of amyloid beta-peptide |
| 04/11/2012 | EP1781612B1 Shortened method for the production of l-lobeline |
| 04/11/2012 | EP1673356B1 Substituted benzylaminoalkylene heterocycles |
| 04/11/2012 | EP1651612B1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 04/11/2012 | EP1575517B1 Anti-ngf antibodies and methods using same |
| 04/11/2012 | EP1503794B1 Methods of treatement using ctla-4 antibodies |
| 04/11/2012 | EP1463528B1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain |
| 04/11/2012 | EP1334120B1 Modified clostridial neurotoxins with altered biological persistence |
| 04/11/2012 | EP1261590B1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 04/11/2012 | EP1220870B1 Metal-binding compounds and uses therefor |
| 04/11/2012 | CN102414210A 作为β-分泌酶抑制剂的取代的咪唑并[1，2-a]吡啶衍生物、药物组合物和使用方法 -secretase Inhibitors as β- substituted imidazo [1,2-a] pyridine derivatives, pharmaceutical compositions and methods of use |
| 04/11/2012 | CN102414209A 运动障碍治疗剂 Dyskinesia therapeutic agent |
| 04/11/2012 | CN102414208A 作为用于认知性障碍的治疗中的gabaa受体逆激动剂的异*唑-噻唑衍生物 As a treatment for cognitive disorders in gabaa receptor inverse agonist iso * azole - thiazole derivatives |
| 04/11/2012 | CN102414206A Isoxazole-pyridine derivatives |
| 04/11/2012 | CN102414205A Isoxazole-pyrazole derivatives |
| 04/11/2012 | CN102414203A Isoxazole-pyridine derivatives as gaba modulators |
| 04/11/2012 | CN102413834A 聚合月桂烯的组合物 Polymerizable composition myrcene |
| 04/11/2012 | CN102413833A 乳香部分的治疗应用 Therapeutic applications frankincense part |
| 04/11/2012 | CN102413828A 作为食欲素受体拮抗剂的噻唑烷-4-酮和[1,3]-噻嗪烷-4-酮化合物 Orexin receptor antagonists as thiazolidine-4-one and [1,3] - thiazine-4-one compound of |
| 04/11/2012 | CN102413822A 提高哺乳动物中内源性缩醛磷脂水平的方法 Improved mammalian endogenous level of a plasmalogen |
| 04/11/2012 | CN102413814A 用于神经保护和治疗神经变性病症的克拉维酸类物质制剂 Clavulanic acids formulations for neuroprotection and treatment of neurodegenerative disorders |
| 04/11/2012 | CN102408998A Salt-tolerant marine mangrove endophytic fungi with neurodegenerative disease control activity |
| 04/11/2012 | CN102408484A 具有wnk激酶抑制作用的重组穿膜肽及其应用 Recombinant kinase inhibition has wnk penetrating peptide and its application |
| 04/11/2012 | CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 04/11/2012 | CN102408433A 含嘧啶的肟类化合物、其制备方法和用途 Oxime-containing pyrimidine compounds, their preparation and use |
| 04/11/2012 | CN102408411A Hydroximic acid compound containing quinolyl and preparation method thereof, and drug composition containing the compound and use thereof |
| 04/11/2012 | CN102408395A Novel piperazine and homopiperazine derivative and preparation method and use thereof |
| 04/11/2012 | CN102408331A 一种二乙酰大黄酸的制备方法 Preparation method of diacetyl rhein |
| 04/11/2012 | CN102406917A 一种抗抑郁的中药组合物及其制备方法 Antidepressant medicine composition and its preparation method |
| 04/11/2012 | CN102406913A 一种治疗郁证的中药组合物 A method of treating depression syndrome of traditional Chinese medicine composition |
| 04/11/2012 | CN102406909A 一种治疗肝硬化腹水的中药配方 A treatment for cirrhosis of the Chinese herbal formula |
| 04/11/2012 | CN102406897A Xingnaojing solid medicinal composition and preparation method thereof |
| 04/11/2012 | CN102406894A 一种治疗经前紧张综合症的中药 A premenstrual tension syndrome of traditional Chinese medicine |
| 04/11/2012 | CN102406883A 一种治疗肝阳上亢引起头痛的中药组合物 A treatment for hyperactivity induced headache medicine composition |
| 04/11/2012 | CN102406881A 一种治疗偏头痛的中药新复方制剂、使用方法及其应用 A method of treating migraine medicine new compound, using method and its application |
| 04/11/2012 | CN102406871A 戒烟茶及其制备方法 Tea and its preparation method to quit smoking |
| 04/11/2012 | CN102406857A 治疗三叉神经痛的中药制剂 Chinese medicine treatment of trigeminal neuralgia |
| 04/11/2012 | CN102406854A 一种治疗不寐的中药组合物 A method of treating insomnia herbal composition |
| 04/11/2012 | CN102406850A 治疗老年性痴呆的中药制剂 Chinese medicine treatment of senile dementia |
| 04/11/2012 | CN102406849A 治疗面神经麻痹的中药制剂 Chinese medicine treatment of facial paralysis |
| 04/11/2012 | CN102406848A 治疗外伤性头痛的中药制剂 Traumatic headache medicine preparations |
| 04/11/2012 | CN102406844A 一种治疗癫痫病的中药制剂及其制备方法 A treatment for epilepsy medicine and its preparation method |
| 04/11/2012 | CN102406833A Comprehensive extraction and utilization technology for creeping liriope |